Short answer
MEDIFAST INC (MED) filed an 8-K current report with the SEC on July 17, 2026 reporting Item 7.01 (Regulation FD Disclosure). OPTAVIA rebranded as Trilivy, repositioning Medifast’s wholly owned lifestyle brand around comprehensive metabolic health.
MEDIFAST INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- OPTAVIA rebranded as Trilivy, repositioning Medifast’s wholly owned lifestyle brand around comprehensive metabolic health
- Strategic shift broadens brand positioning beyond traditional weight management toward an integrated metabolic-health offering
- Exhibit 99.1 contains the company’s detailed announcement and supporting rationale
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MEDIFAST INC 8-K filings
Get the next MED 8-K as it lands
Follow MED for push alerts, or ask the research agent what this filing means.